rs121918696
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM2PP2PP3_StrongPP5_Very_Strong
The NM_001354712.2(THRB):c.958C>T(p.Arg320Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001354712.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
THRB | NM_001354712.2 | c.958C>T | p.Arg320Cys | missense_variant | 10/11 | ENST00000646209.2 | NP_001341641.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
THRB | ENST00000646209.2 | c.958C>T | p.Arg320Cys | missense_variant | 10/11 | NM_001354712.2 | ENSP00000496686 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461858Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727236
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Thyroid hormone resistance, generalized, autosomal dominant Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 1993 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital | Oct 20, 2010 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 25, 2024 | Variant summary: THRB c.958C>T (p.Arg320Cys) results in a non-conservative amino acid change located in the Nuclear hormone receptor, ligand-binding domain (IPR000536) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251466 control chromosomes (gnomAD). c.958C>T has been reported in the literature in multiple individuals affected with Thyroid Hormone Resistance, Generalized, Autosomal Dominant with evidence of cosegregation with disease (e.g. Burman_1992). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, finding that the variant results in substantially reduced T3 binding (Burman_1992). The following publication has been ascertained in the context of this evaluation (PMID: 1358935). ClinVar contains an entry for this variant (Variation ID: 12557). Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 03, 2022 | Reported in the heterozygous state (as c.1243C>T due to alternate nomenclature) in multiple individuals from unrelated families with resistance to thyroid hormone (Burman et al., 1992; Weiss et al., 1993; Jonas and Daumerie, 2014); Published functional studies demonstrate a damaging effect: modestly reduced T3 binding affinity compared to normal or wild type translation products (Burman et al., 1992); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33524107, 30430796, 21703645, 9086567, 35738449, 20237409, 30526530, 28938413, 34556608, 34727089, 30027432, 1358935, 8514853, 25099553, 26582918, 24077912) - |
Pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jun 25, 2020 | In the published literature, the variant has been reported to segregate with disease in families affected with resistance to thyroid hormone, and functional studies indicate this variant results in a hormone binding defect (PMID: 1358935 (1992), 8514853 (1993), 9086567 (1997), 21703645 (2011)). It has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). Based on the available information, this variant is classified as pathogenic. - |
Selective pituitary resistance to thyroid hormone;C2937288:Thyroid hormone resistance, generalized, autosomal dominant;C3489796:Thyroid hormone resistance, generalized, autosomal recessive Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 15, 2022 | - - |
THRB-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 04, 2024 | The THRB c.958C>T variant is predicted to result in the amino acid substitution p.Arg320Cys. This variant has been reported in multiple unrelated patients with thyroid hormone resistance (Burman et al. 1992. PubMed ID: 1358935; Weiss et al. 1997. PubMed ID: 9086567; Zaig et al. 2018. PubMed ID: 30430796). Experimental studies suggest this variant impacts protein function by decreasing the affinity of T3 binding (Burman et al. 1992. PubMed ID: 1358935; Lado Abeal et al. 2011. PubMed ID: 21703645). Alternate nucleotide changes affecting the same amino acid (p.Arg320Ser, p.Arg320Gly, p.Arg320His, p.Arg320Pro, p.Arg320Leu), have been reported to be disease-causing for thyroid hormone resistance (Human Gene Mutation Database). This variant has not been reported in a large population database, indicating this variant is rare. Taken together, we interpret this variant as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at